Search

Showing "11154" results for ""

Co-trimoxazole affects survival, CD4 counts, viral load, in HIV-positive Ugandans

More opportunistic infections seen in women cocaine and opiate users, but no effect of drug use on CD4s or viral load

PEPFAR: US is tackling HIV drug supply in wrong way, say Christian hospitals

Nevirapine effect on 'good' cholesterol outranks efavirenz or statins, 2NN study reports

Hepatitis B and C co-infection management a postcode lottery in UK

One in five syphilis cases in Chicago gay men due to oral sex

Hepatitis A outbreak reported among gay men in Norway

Treatment interruption 'safe' in those with lowest-ever CD4 counts above 250 cells/mm3

Treatment interruption results in lipid reduction; IL-2 has no effect on lipids

Drug side-effects place treatment scale up at risk, says Ugandan HIV expert

AZT & d4T damage fat cells long before fat loss visible

ICAAC: Fall in immune cells predicts reaction to abacavir, and high incidence of reaction if abacavir used during primary infection

ICAAC: Treatment breaks riskier if NNRTIs involved

ICAAC: Mitochondrial DNA level in blood may provide early warning of lipodystrophy

ICAAC: African-Americans less likely to experience immunologic failure when taking efavirenz

ICAAC: Men shed HIV in sexual fluids more often than women

ICAAC: When to use T-20: new analysis shows risk of leaving it too late

ICAAC: Kaletra exposure decreased by tenofovir in experienced HIV patients

Receive the latest HIV research and conference news

Showing "11154" results for ""

Co-trimoxazole affects survival, CD4 counts, viral load, in HIV-positive Ugandans

More opportunistic infections seen in women cocaine and opiate users, but no effect of drug use on CD4s or viral load

PEPFAR: US is tackling HIV drug supply in wrong way, say Christian hospitals

Nevirapine effect on 'good' cholesterol outranks efavirenz or statins, 2NN study reports

Hepatitis B and C co-infection management a postcode lottery in UK

One in five syphilis cases in Chicago gay men due to oral sex

Hepatitis A outbreak reported among gay men in Norway

Treatment interruption 'safe' in those with lowest-ever CD4 counts above 250 cells/mm3

Treatment interruption results in lipid reduction; IL-2 has no effect on lipids

Drug side-effects place treatment scale up at risk, says Ugandan HIV expert

AZT & d4T damage fat cells long before fat loss visible

ICAAC: Fall in immune cells predicts reaction to abacavir, and high incidence of reaction if abacavir used during primary infection

ICAAC: Treatment breaks riskier if NNRTIs involved

ICAAC: Mitochondrial DNA level in blood may provide early warning of lipodystrophy

ICAAC: African-Americans less likely to experience immunologic failure when taking efavirenz

ICAAC: Men shed HIV in sexual fluids more often than women

ICAAC: When to use T-20: new analysis shows risk of leaving it too late

ICAAC: Kaletra exposure decreased by tenofovir in experienced HIV patients

Receive the latest HIV research and conference news